Literature DB >> 9245708

Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages.

Y M Kim1, B S Lee, K Y Yi, S G Paik.   

Abstract

Transient transfection assays with various deletion mutants of the mouse inducible nitric oxide synthase (iNOS) promoter linked to a CAT reporter gene demonstrated that, besides the downstream NF-kappaB site, the region from -973 to -925 which contains a potential binding site for NF-kappaB (upstream NF-kappaB site) also mediated lipopolysaccharide (LPS)-inducibility in mouse macrophage cell line RAW 264.7. Site-specific mutation of three conserved nucleotides within the upstream NF-kappaB site abolished additional induction by LPS as well as maximal expression of iNOS by IFN-gamma plus LPS. In contrast, site-specific mutation of the downstream NF-kappaB site caused almost all reduction in expression of the reporter gene by LPS or LPS plus IFN-gamma. Electrophoretic mobility shift assays with the two NF-kappaB sites showed LPS-induced NF-kappaB binding to both probes and its higher affinity to the upstream NF-kappaB site. Taken together, these suggest that the upstream NF-kappaB site having enhancer function, besides the downstream NF-kappaB site as a core promoter, is essential for maximal expression of the iNOS gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9245708     DOI: 10.1006/bbrc.1997.7031

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  E3 ubiquitin ligase NKLAM positively regulates macrophage inducible nitric oxide synthase expression.

Authors:  Donald W Lawrence; Gail Gullickson; Jacki Kornbluth
Journal:  Immunobiology       Date:  2014-08-23       Impact factor: 3.144

2.  Non-NF-kappaB elements are required for full induction of the rat type II nitric oxide synthase in vascular smooth muscle cells.

Authors:  H Zhang; X Teng; C Snead; J D Catravas
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Activation and mitogen-activated protein kinase regulation of transcription factors Ets and NF-kappaB in Mycobacterium-infected macrophages and role of these factors in tumor necrosis factor alpha and nitric oxide synthase 2 promoter function.

Authors:  Seong-Beom Lee; Jeffrey S Schorey
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  A molecular pharmacology study into the anti-inflammatory actions of Euphorbia hirta L. on the LPS-induced RAW 264.7 cells through selective iNOS protein inhibition.

Authors:  Mei-Fen Shih; Yih-Dih Cheng; Chia-Rui Shen; Jong-Yuh Cherng
Journal:  J Nat Med       Date:  2010-07       Impact factor: 2.343

5.  The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages.

Authors:  Daniela De Stefano; Maria Chiara Maiuri; Barbara Iovine; Armando Ialenti; Maria Assunta Bevilacqua; Rosa Carnuccio
Journal:  J Mol Med (Berl)       Date:  2005-11-12       Impact factor: 4.599

6.  Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB.

Authors:  J Whan Han; B Gon Lee; Y Kee Kim; J Woo Yoon; H Kyoung Jin; S Hong; H Young Lee; K Ro Lee; H Woo Lee
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

7.  Gliadin increases iNOS gene expression in interferon-gamma-stimulated RAW 264.7 cells through a mechanism involving NF-kappa B.

Authors:  Maria Chiara Maiuri; Daniela De Stefano; Guido Mele; Barbara Iovine; Maria Assunta Bevilacqua; Luigi Greco; Salvatore Auricchio; Rosa Carnuccio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-04       Impact factor: 3.000

8.  Inhibition of Plasmodium falciparum field isolates-mediated endothelial cell apoptosis by Fasudil: therapeutic implications for severe malaria.

Authors:  Estelle S Zang-Edou; Ulrick Bisvigou; Zacharie Taoufiq; Faustin Lékoulou; Jean Bernard Lékana-Douki; Yves Traoré; Dominique Mazier; Fousseyni S Touré-Ndouo
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

9.  Inhibitory mechanism of 10-hydroxy-trans-2-decenoic acid (royal jelly acid) against lipopolysaccharide- and interferon-β-induced nitric oxide production.

Authors:  Tsuyoshi Sugiyama; Keita Takahashi; Akihiro Kuzumaki; Shunji Tokoro; Paola Neri; Hiroshi Mori
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

10.  Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1).

Authors:  Julie Blanchette; Issa Abu-Dayyeh; Kasra Hassani; Lorie Whitcombe; Martin Olivier
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.